These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32996987)

  • 1. A versatile UCST-type composite microsphere for image-guided chemoembolization and photothermal therapy against liver cancer.
    Huang D; Dai H; Tang K; Chen B; Zhu H; Chen D; Li N; Wang Y; Liu C; Huang Y; Yang J; Zhang C; Lin R; He W
    Nanoscale; 2020 Oct; 12(38):20002-20015. PubMed ID: 32996987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic mesoporous embolic microspheres in transcatheter arterial chemoembolization for liver cancer.
    Liu L; Liang X; Xu X; Zhang X; Wen J; Chen K; Su X; Teng Z; Lu G; Xu J
    Acta Biomater; 2021 Aug; 130():374-384. PubMed ID: 34082098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-Eluting Microsphere Versus Cisplatin-Based Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: Propensity Score-Matched Analysis.
    Chu HH; Gwon DI; Kim JH; Ko GY; Shin JH; Yoon HK
    AJR Am J Roentgenol; 2020 Sep; 215(3):745-752. PubMed ID: 32569514
    [No Abstract]   [Full Text] [Related]  

  • 4. Transarterial Chemoembolization of HCC with Radiopaque Microspheres: Evaluation with Computed Tomography and the Complementary Role of Contrast-Enhanced Ultrasonography.
    Moschouris H; Malagari K; Dimakis A; Kiakidis T; Anagnostopoulou A
    Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1075-1083. PubMed ID: 32394087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local application of doxorubicin- loaded Iron oxid nanoparticles and the vascular disrupting agent via the hepatic artery: chemoembolization-photothermal ablation treatment of hepatocellular carcinoma in rats.
    Yuan H; Li X; Tang J; Zhou M; Liu F
    Cancer Imaging; 2019 Nov; 19(1):71. PubMed ID: 31685015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial chemoembolization for hepatocellular carcinoma with a new generation of beads: clinical-radiological outcomes and safety profile.
    Spreafico C; Cascella T; Facciorusso A; Sposito C; Rodolfo L; Morosi C; Civelli EM; Vaiani M; Bhoori S; Pellegrinelli A; Marchianò A; Mazzaferro V
    Cardiovasc Intervent Radiol; 2015 Feb; 38(1):129-34. PubMed ID: 24870698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin-Loaded UiO-66/Bi
    Liu L; Zhuang J; Tan J; Liu T; Fan W; Zhang Y; Li J
    ACS Appl Mater Interfaces; 2022 Feb; 14(6):7579-7591. PubMed ID: 35129950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoembolization of liver cancer with drug-loading microsphere 50-100μm.
    Sun JH; Zhou GH; Zhang YL; Nie CH; Zhou TY; Ai J; Zhu TY; Wang WL; Zheng SS
    Oncotarget; 2017 Jan; 8(3):5392-5399. PubMed ID: 28036272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT/MR detectable magnetic microspheres for self-regulating temperature hyperthermia and transcatheter arterial chemoembolization.
    Wei C; Wu C; Jin X; Yin P; Yu X; Wang C; Zhang W
    Acta Biomater; 2022 Nov; 153():453-464. PubMed ID: 36167241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioiodine-131-Labeled Theranostic Nanoparticles for Transarterial Radioembolization and Chemoembolization Combination Therapy of VX2 Liver Tumor.
    Jia G; Wang T; Li R; Li X; Sun G; Chen W; Peng Y; Cheng C; Yang J; Zuo C
    Adv Healthc Mater; 2023 Dec; 12(32):e2301559. PubMed ID: 37807421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma.
    Park KH; Kwon SH; Lee YS; Jeong SW; Jang JY; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS; Kim YJ
    Clin Mol Hepatol; 2015 Jun; 21(2):158-64. PubMed ID: 26157753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver chemoembolization of hepatocellular carcinoma using TANDEM
    Delicque J; Guiu B; Boulin M; Schwanz H; Piron L; Cassinotto C
    Future Oncol; 2018 Nov; 14(26):2761-2772. PubMed ID: 29953255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: a meta-analysis.
    Ni JY; Xu LF; Wang WD; Sun HL; Chen YT
    World J Gastroenterol; 2014 Dec; 20(45):17206-17. PubMed ID: 25493037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering polyvinyl alcohol microspheres with capability for use in photothermal/chemodynamic therapy for enhanced transarterial chemoembolization.
    Lu X; Liu Q; Yan G; Wang X; Liu X; Tian Q; Song S
    J Mater Chem B; 2024 May; 12(21):5207-5219. PubMed ID: 38693796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoembolization Adopting Polyethylene Glycol Drug-Eluting Embolics Loaded With Doxorubicin for the Treatment of Hepatocellular Carcinoma.
    Aliberti C; Carandina R; Sarti D; Mulazzani L; Pizzirani E; Guadagni S; Fiorentini G
    AJR Am J Roentgenol; 2017 Aug; 209(2):430-434. PubMed ID: 28537756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
    Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M
    Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular Carcinoma: Intra-arterial Delivery of Doxorubicin-loaded Hollow Gold Nanospheres for Photothermal Ablation-Chemoembolization Therapy in Rats.
    Li J; Zhou M; Liu F; Xiong C; Wang W; Cao Q; Wen X; Robertson JD; Ji X; Wang YA; Gupta S; Li C
    Radiology; 2016 Nov; 281(2):427-435. PubMed ID: 27347765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoembolization of liver cancer with doxorubicin-loaded CalliSpheres microspheres: plasma pharmacokinetics, intratumoral drug concentration, and tumor necrosis in a rabbit model.
    Liang B; Zhao D; Liu Y; Guo X; Zhang H; Zhang L; Zheng C
    Drug Deliv Transl Res; 2020 Feb; 10(1):185-191. PubMed ID: 31482517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial Chemoembolization Using 100-μm Drug-Eluting Microspheres in Patients with Hepatocellular Carcinoma: A Prospective Study and Midterm Follow-up.
    Ou HY; Wu YN; Yu CY; Chen CL; Hsu HW; Weng CC; Leung-Chit Tsang L; Huang TL; Tong YS; Lim WX; Cheng YF
    J Vasc Interv Radiol; 2020 Nov; 31(11):1784-1791. PubMed ID: 33023805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradable starch microspheres transarterial chemoembolization (DSMs-TACE) in patients with unresectable hepatocellular carcinoma (HCC): long-term results from a single-center 137-patient cohort prospective study.
    Orlacchio A; Chegai F; Roma S; Merolla S; Bosa A; Francioso S
    Radiol Med; 2020 Jan; 125(1):98-106. PubMed ID: 31583558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.